Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Svoronos Dawn, Director. Director active across 5 companies, notably PTC Therapeutics, INC.. Aggregated, 14 filings have been published. Breakdown: 2 buys · 7 sells. Total volume traded: €1.3m. Activity tracked since 9 June 2021. The latest transaction was disclosed on 24 August 2023 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
365 shares@ US$41.88515.9% of flowCommon StockSEC:0001179110-21-006598
14 of 14 declarations
About Svoronos Dawn
Dawn Svoronos is a Board Member at PTC THERAPEUTICS, INC., Global Blood Therapeutics, Inc., and Adverum Biotechnologies, Inc. She brings expertise in corporate governance and strategic development. Her role is crucial in guiding board decisions and ensuring compliance with regulatory standards.